Bellicum Pharmaceuticals Inc. buy marge
Start price
17.04.17
/
50%
€120.87
Target price
13.12.19
€162.36
Performance (%)
-93.05%
End price
13.12.19
€8.40
Summary
This prediction ended on 13.12.19 with a price of €8.40. Massive losses of -93.05% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bellicum Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
Comments by marge for this prediction
In the thread Bellicum Pharmaceuticals Inc. diskutieren
marge stimmt der Buy-Einschätzung von datca zu
marge stimmt am 17.04.2017 der Buy-Einschätzung von datca mit dem Kursziel 18$ zu.Überschrift: BLCM mit beeindruckenden Daten bei Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Buy beendet
Stopped prediction by marge for Bellicum Pharmaceuticals Inc.
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.40
13.12.19
13.12.19
€7.00
04.11.21
04.11.21
-79.17%
05.11.21
05.11.21